Pages that link to "Q80929661"

The following pages link to Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability (Q80929661):

Displaying 30 items.

• Parkinson's disease as a result of aging (Q28084395) (← links)
• Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration (Q30373366) (← links)
• Localization of synucleins in the mammalian cochlea (Q30484963) (← links)
• Evaluation of alpha-synuclein immunohistochemical methods used by invited experts (Q30488694) (← links)
• Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions (Q33556006) (← links)
• Embryonic development of selectively vulnerable neurons in Parkinson's disease. (Q33835242) (← links)
• Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium (Q34023599) (← links)
• Parkinson's disease: a dual-hit hypothesis (Q34706775) (← links)
• Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa (Q35614156) (← links)
• Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein (Q36400251) (← links)
• Non-motor aspects of Parkinson's disease. (Q36525764) (← links)
• Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies (Q36722186) (← links)
• Prion-like spreading of pathological α-synuclein in brain (Q36732844) (← links)
• Association Between Autonomic Impairment and Structural Deficit in Parkinson Disease (Q36822812) (← links)
• Cortical thinning is associated with disease stages and dementia in Parkinson's disease (Q37030350) (← links)
• Therapies for human prion diseases (Q37199225) (← links)
• Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction (Q37376010) (← links)
• Formation and development of Lewy pathology: a critical update (Q37587790) (← links)
• Synuclein deposition and non-motor symptoms in Parkinson disease (Q37875341) (← links)
• Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts (Q37955871) (← links)
• Staged pathology in Parkinson's disease (Q38164891) (← links)
• Neuropathobiology of non-motor symptoms in Parkinson disease (Q38481481) (← links)
• Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease. (Q42653035) (← links)
• Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS). (Q46895728) (← links)
• Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway. (Q52718062) (← links)
• Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? (Q54982491) (← links)
• Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system applied (Q64769163) (← links)
• Is Braak staging valid for all types of Parkinson's disease? (Q89251186) (← links)
• Alpha-synuclein fragments trigger distinct aggregation pathways (Q89518306) (← links)
• Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging (Q90028599) (← links)